AB
MIRM icon

Amalgamated Bank’s Mirum Pharmaceuticals MIRM Stock Holding History

Amalgamated Bank’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,288
Closed -$102K – 2342
2025
Q4 		$102K Sell
1,288
-74
-5% -$5.31K ﹤0.01% 1697
2025
Q3 		$100K Hold
1,362
– – ﹤0.01% 1702
2025
Q2 		$69K Hold
1,362
– – ﹤0.01% 1765
2025
Q1 		$61K Buy
1,362
+5
+0.4% +$236 ﹤0.01% 1760
2024
Q4 		$56K Hold
1,357
– – ﹤0.01% 1810
2024
Q3 		$53K Hold
1,357
– – ﹤0.01% 1827
2024
Q2 		$46K Buy
1,357
+513
+61% +$13.4K ﹤0.01% 1868
2024
Q1 		$21K Sell
844
-2,660
-76% -$73.1K ﹤0.01% 2105
2023
Q4 		$103K Buy
3,504
+135
+4% +$4.09K ﹤0.01% 1988
2023
Q3 		$106K Sell
3,369
-385
-10% -$10.5K ﹤0.01% 1975
2023
Q2 		$97K Buy
3,754
+1,145
+44% +$30.5K ﹤0.01% 2075
2023
Q1 		$63K Sell
2,609
-194
-7% -$4.42K ﹤0.01% 2216
2022
Q4 		$55K Hold
2,803
– – ﹤0.01% 2378
2022
Q3 		$59K Buy
2,803
+292
+12% +$7.03K ﹤0.01% 2385
2022
Q2 		$49K Buy
2,511
+1,995
+387% +$47.1K ﹤0.01% 2495
2022
Q1 		$11K Buy
+516
New +$10.5K ﹤0.01% 2943

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Amalgamated Bank's MIRM Position: Q1 2026 in Review

Amalgamated Bank sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 1,288 shares — an estimated $102K sold.

Amalgamated Bank first reported a position in MIRM in Q1 2022 and held it in 16 quarters. The position peaked at $106K in Q3 2023. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Amalgamated Bank reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,288 Mirum Pharmaceuticals shares in Q1 2026, an estimated $102K.
  • Amalgamated Bank first reported a position in Mirum Pharmaceuticals in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Mirum Pharmaceuticals position peaked at $106K in Q3 2023.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.